These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 21482863

  • 1. Topical treatment of hypertensive leg ulcers with platelet-derived growth factor-BB: a randomized controlled trial.
    Senet P, Vicaut E, Beneton N, Debure C, Lok C, Chosidow O.
    Arch Dermatol; 2011 Aug; 147(8):926-30. PubMed ID: 21482863
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of a topical gel formulation of recombinant human platelet-derived growth factor-BB (becaplermin) in patients with chronic neuropathic diabetic ulcers. A phase III randomized placebo-controlled double-blind study.
    Wieman TJ, Smiell JM, Su Y.
    Diabetes Care; 1998 May; 21(5):822-7. PubMed ID: 9589248
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and safety of becaplermin (recombinant human platelet-derived growth factor-BB) in patients with nonhealing, lower extremity diabetic ulcers: a combined analysis of four randomized studies.
    Smiell JM, Wieman TJ, Steed DL, Perry BH, Sampson AR, Schwab BH.
    Wound Repair Regen; 1999 May; 7(5):335-46. PubMed ID: 10564562
    [Abstract] [Full Text] [Related]

  • 4. Becaplermin gel in the treatment of pressure ulcers: a phase II randomized, double-blind, placebo-controlled study.
    Rees RS, Robson MC, Smiell JM, Perry BH.
    Wound Repair Regen; 1999 May; 7(3):141-7. PubMed ID: 10417749
    [Abstract] [Full Text] [Related]

  • 5. Recombinant human platelet-derived growth factor-BB (becaplermin) for healing chronic lower extremity diabetic ulcers: an open-label clinical evaluation of efficacy.
    Embil JM, Papp K, Sibbald G, Tousignant J, Smiell JM, Wong B, Lau CY.
    Wound Repair Regen; 2000 May; 8(3):162-8. PubMed ID: 10886806
    [Abstract] [Full Text] [Related]

  • 6. A phase II study to evaluate recombinant platelet-derived growth factor-BB in the treatment of stage 3 and 4 pressure ulcers.
    Mustoe TA, Cutler NR, Allman RM, Goode PS, Deuel TF, Prause JA, Bear M, Serdar CM, Pierce GF.
    Arch Surg; 1994 Feb; 129(2):213-9. PubMed ID: 8304833
    [Abstract] [Full Text] [Related]

  • 7. [Hypertensive leg ulcers: epidemiological characteristics and prognostic factors for healing in a prospective cohort].
    Senet P, Beneton N, Debure C, Modiano P, Lok C, Bedane C, Truchetet F, Fays-Bouchon S, Vicaut E, Chosidow O, Angio-dermatologie de la SFD.
    Ann Dermatol Venereol; 2012 May; 139(5):346-9. PubMed ID: 22578337
    [Abstract] [Full Text] [Related]

  • 8. Topical PDGF-BB results in limited healing in a patient with Werner's syndrome and chronic leg ulcers.
    Wollina U, Gruner M, Koch A, Köstler E, Hubl W, Hanson NB, Oshima J.
    J Wound Care; 2004 Nov; 13(10):415-6. PubMed ID: 15575568
    [Abstract] [Full Text] [Related]

  • 9. Platelet-derived growth factor BB for the treatment of chronic pressure ulcers.
    Robson MC, Phillips LG, Thomason A, Robson LE, Pierce GF.
    Lancet; 1992 Jan 04; 339(8784):23-5. PubMed ID: 1345953
    [Abstract] [Full Text] [Related]

  • 10. Use of topical recombinant human platelet-derived growth factor BB in abdominal wound separation.
    Shackelford DP, Fackler E, Hoffman MK, Atkinson S.
    Am J Obstet Gynecol; 2002 Apr 04; 186(4):701-4. PubMed ID: 11967494
    [Abstract] [Full Text] [Related]

  • 11. Clinical efficacy of becaplermin (rhPDGF-BB) gel. Becaplermin Gel Studies Group.
    Wieman TJ.
    Am J Surg; 1998 Aug 04; 176(2A Suppl):74S-79S. PubMed ID: 9777976
    [Abstract] [Full Text] [Related]

  • 12. Clinical evaluation of recombinant human platelet-derived growth factor for the treatment of lower extremity diabetic ulcers. Diabetic Ulcer Study Group.
    Steed DL.
    J Vasc Surg; 1995 Jan 04; 21(1):71-8; discussion 79-81. PubMed ID: 7823364
    [Abstract] [Full Text] [Related]

  • 13. Successful treatment of chronic wound in Klippel-Trenaunay syndrome with recombinant human platelet-derived growth factor-BB.
    Danikas D, Theodorou SJ, Wurmser E.
    Plast Reconstr Surg; 2002 Jun 04; 109(7):2608-9. PubMed ID: 12045617
    [No Abstract] [Full Text] [Related]

  • 14. Proliferation and mitogenic response to PDGF-BB of fibroblasts isolated from chronic venous leg ulcers is ulcer-age dependent.
    Agren MS, Steenfos HH, Dabelsteen S, Hansen JB, Dabelsteen E.
    J Invest Dermatol; 1999 Apr 04; 112(4):463-9. PubMed ID: 10201530
    [Abstract] [Full Text] [Related]

  • 15. Original articles: ease of wound closure as an endpoint of treatment efficacy.
    Robson MC, Maggi SP, Smith PD, Wassermann RJ, Mosiello GC, Hill DP, Cooper DM.
    Wound Repair Regen; 1999 Apr 04; 7(2):90-6. PubMed ID: 10231510
    [Abstract] [Full Text] [Related]

  • 16. Randomized clinical trial comparing OASIS Wound Matrix to Regranex Gel for diabetic ulcers.
    Niezgoda JA, Van Gils CC, Frykberg RG, Hodde JP.
    Adv Skin Wound Care; 2005 Jun 04; 18(5 Pt 1):258-66. PubMed ID: 15942317
    [Abstract] [Full Text] [Related]

  • 17. Role of platelet-derived growth factor as an adjunct to surgery in the management of pressure ulcers.
    Kallianinen LK, Hirshberg J, Marchant B, Rees RS.
    Plast Reconstr Surg; 2000 Nov 04; 106(6):1243-8. PubMed ID: 11083552
    [Abstract] [Full Text] [Related]

  • 18. Treatment of scleroderma skin ulcers using becaplermin gel and hydrocolloid membrane.
    Yoon J, Giacopelli J, Granoff D, Kobayashi W.
    J Am Podiatr Med Assoc; 2002 Jun 04; 92(6):350-4. PubMed ID: 12070235
    [Abstract] [Full Text] [Related]

  • 19. Diabetic foot ulcers treated with becaplermin and TheraGauze, a moisture-controlling smart dressing: a randomized, multicenter, prospective analysis.
    Landsman A, Agnew P, Parish L, Joseph R, Galiano RD.
    J Am Podiatr Med Assoc; 2010 Jun 04; 100(3):155-60. PubMed ID: 20479444
    [Abstract] [Full Text] [Related]

  • 20. Cost-effectiveness of becaplermin for nonhealing neuropathic diabetic foot ulcers.
    Sibbald RG, Torrance G, Hux M, Attard C, Milkovich N.
    Ostomy Wound Manage; 2003 Nov 04; 49(11):76-84. PubMed ID: 14652415
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.